- Brokerages recommend buying Max Healthcare with targets around Rs 1,150-1,160 and stop-loss near Rs 1,085
- Aurobindo Pharma advised as a 'buy' with targets between Rs 1,250 and Rs 1,285 and stop-loss at Rs 1,190
- Bharat Electronics is a 'buy' at Rs 450 with a target of Rs 460 and stop-loss set at Rs 445
Brokerage firms and market analysts issued fresh trading ideas for today's session with opportunities across banking, metal, auto and energy counters. Most experts expect continued momentum in large-cap and mid-cap stocks. Here are the key intraday and short-term picks recommended by top analysts.
Max Healthcare Institute Ltd. (CMP: Rs 1,106.45)
Rajesh Bhosale, Equity Technical and Derivative Analyst, Angel One, recommended a buy on Max Healthcare Institute Ltd. at Rs 1,110, with a stop-loss at Rs 1,084 and a target of Rs 1,160. Shrikant Chouhan from Kotak Securities also recommended a buy on Max Healthcare, with a target price of Rs 1,150 and a stop-loss of Rs 1,085.
Aurobindo Pharma Ltd. (CMP: Rs 1,221.70)
Gaurav Sharma, Associate VP & HOR Globe Capital recommended a buy on Aurobindo Pharma Ltd. at the current market price of Rs 1,215, with a stop-loss at Rs 1,190 and target price of Rs 1,250 and Rs 1,285.
Bharat Electronics Ltd. (CMP: Rs 449.30)
Raja Venkatraman, Co-Founder, NeoTrader recommended a buy on Bharat Electronics Ltd. (BEL) at Rs 450, with a stop-loss at Rs 445 and a target of Rs 460.
Fortis Healthcare Ltd. (CMP: 965.00)
Rajesh Palviya, SVP - Technical and Derivatives Research, Axis Securities recommended a buy on Fortis Healthcare Ltd. at Rs 963, with a stop-loss at Rs 945 and a target of Rs 988. Raja Venkatraman from NeoTrader has also recommended a buy on Fortis at Rs 965, with a stop-loss at Rs 948 and a target of Rs 990.
Trent Ltd (CMP: 3,861.00)
Shrikant Chouhan, Executive VP & Head Equity Research, Kotak Sec, recommended a sell on Trent Ltd., with a target of Rs 3,725 and a stop-loss of Rs 3,925.
ALSO READ: Stock Picks Today: Tata Motors, Bajaj Finance, Kansai Nerolac And More On Brokerages' Radar
Disclaimer: The views and opinions expressed by the investment advisers on NDTV Profit are of their own and not of NDTV Profit. NDTV Profit advises users to consult with their own financial or investment adviser before taking any investment decision.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.